Compare $CLYM vs $CTMX | Chartloom

Compare

$CLYM vs $CTMX

Climb Bio Inc · CytomX Therapeutics Inc

CLYM

Climb Bio Inc

CTMX

CytomX Therapeutics Inc

Compare $CLYM vs $CTMX

Comparing Climb Bio Inc and CytomX Therapeutics Inc

CLYMClimb Bio Inc

CTMXCytomX Therapeutics Inc

CLYMClimb Bio Inc

Market cap

$630M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

193.3%

52W performance

511.1%

FCF yield

-8.4%

CTMXCytomX Therapeutics Inc

Market cap

$559M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

32.52x

Rev growth (TTM)

-87.0%

YTD performance

-39.5%

52W performance

-23.7%

FCF yield

-14.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLYM

CTMX

Detailed metrics comparison

CLYM

Climb Bio Inc

CTMX

CytomX Therapeutics Inc

Market Cap

CLYM$630M

CTMX$559M

Enterprise Value

CLYM$586M

CTMX$542M

Price

CLYM$11.00

CTMX$2.57

P/E Ratio

CLYMN/A

CTMXN/A

P/S Ratio

CLYM0.00x

CTMX30.57x

EV/Sales

CLYM0.00x

CTMX29.63x

EV/EBITDA

CLYM0.00x

CTMX22.17x

P/B Ratio

CLYM2.62x

CTMX1.85x

P/FCF Ratio

CLYMN/A

CTMXN/A

EV/FCF

CLYM-11.04x

CTMX-6.55x

PEG Ratio

CLYMN/A

CTMXN/A

Forward P/E (NTM)

CLYMN/A

CTMXN/A

Forward P/S (NTM)

CLYMN/A

CTMX32.52x

Revenue (TTM)

CLYM$0

CTMX$18M

Revenue Growth (YoY)

CLYMN/A

CTMX-87.0%

Forward Rev Growth

CLYM27.3%

CTMX35.7%

Gross Margin (TTM)

CLYM0.0%

CTMX0.0%

Operating Margin (TTM)

CLYM0.0%

CTMX0.0%

EBITDA Margin (TTM)

CLYM0.0%

CTMX-471.6%

Net Margin (TTM)

CLYM0.0%

CTMX-451.6%

FCF Margin (TTM)

CLYMN/A

CTMX-452.1%

Net Income (TTM)

CLYM$-58M

CTMX$-83M

FCF (TTM)

CLYM$-53M

CTMX$-83M

EPS (TTM)

CLYM-$0.76

CTMX-$0.38

ROE (TTM)

CLYM-3179.0%

CTMX-3846.0%

ROA (TTM)

CLYM-3079.0%

CTMX-3033.0%

ROIC (TTM)

CLYM-3179.0%

CTMX-3846.0%

Cash

CLYM$44M

CTMX$17M

Debt

CLYM$0

CTMX$0

Net Cash/Debt

CLYM$44M

CTMX$17M

Current Ratio (TTM)

CLYM31.45x

CTMX9.36x

Quick Ratio (TTM)

CLYM30.86x

CTMX9.25x

Debt/Equity (TTM)

CLYM0.00x

CTMX0.00x

Debt/Assets (TTM)

CLYM0.0%

CTMX0.0%

Interest Coverage (TTM)

CLYMN/A

CTMXN/A

Net Debt/EBITDA (TTM)

CLYM0.00x

CTMX0.00x

Beta

CLYM-0.01

CTMX2.26

52W Performance

CLYM511.1%

CTMX-23.7%

YTD Performance

CLYM193.3%

CTMX-39.5%

% from 52W High

CLYM-40.0%

CTMX-68.7%

% from 52W Low

CLYM572.8%

CTMX5.8%

Asset Turnover (TTM)

CLYM0.00x

CTMX0.07x

FCF Yield (TTM)

CLYM-8.4%

CTMX-14.8%

Earnings Yield (TTM)

CLYM-9.1%

CTMX-14.8%

Dividend Yield (TTM)

CLYMN/A

CTMXN/A

Rule of 40

CLYM0.0

CTMX-539.1

EV/GP/RG

CLYMN/A

CTMXN/A

Ticker research

View CLYM research View CTMX research

Metric	CLYM Climb Bio Inc	CTMX CytomX Therapeutics Inc
Market & Valuation
Market Cap	$630M	$559M
Enterprise Value	$586M	$542M
Price	$11.00	$2.57
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	30.57x
EV/Sales	0.00x	29.63x
EV/EBITDA	0.00x	22.17x
P/B Ratio	2.62x	1.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.04x	-6.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	32.52x
Revenue & Growth
Revenue (TTM)	$0	$18M
Revenue Growth (YoY)	N/A	-87.0%
Forward Rev Growth	27.3%	35.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-471.6%
Net Margin (TTM)	0.0%	-451.6%
FCF Margin (TTM)	N/A	-452.1%
Net Income (TTM)	$-58M	$-83M
FCF (TTM)	$-53M	$-83M
EPS (TTM)	-$0.76	-$0.38
ROE (TTM)	-3179.0%	-3846.0%
ROA (TTM)	-3079.0%	-3033.0%
ROIC (TTM)	-3179.0%	-3846.0%
Financial Health
Cash	$44M	$17M
Debt	$0	$0
Net Cash/Debt	$44M	$17M
Current Ratio (TTM)	31.45x	9.36x
Quick Ratio (TTM)	30.86x	9.25x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.01	2.26
52W Performance	511.1%	-23.7%
YTD Performance	193.3%	-39.5%
% from 52W High	-40.0%	-68.7%
% from 52W Low	572.8%	5.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.07x
FCF Yield (TTM)	-8.4%	-14.8%
Earnings Yield (TTM)	-9.1%	-14.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-539.1
EV/GP/RG	N/A	N/A
Ticker research	View CLYM research	View CTMX research

Valuation

P/S Ratio

CLYM

0.00x

CTMX

30.57x

EV/FCF

CLYM

-11.04x

CTMX

-6.55x

Growth & revenue

Revenue Growth TTM

CTMX

-87.0%

Forward Revenue Growth

CTMX

35.7%

CLYM

27.3%

Profitability & performance

Gross Margin

CLYM

0.0%

CTMX

0.0%

ROE

CLYM

-3179.0%

CTMX

-3846.0%

FCF Yield %

CLYM

-8.4%

CTMX

-14.8%

52-Week Performance

CLYM

511.1%

CTMX

-23.7%

Detailed metrics comparison

CLYM

Climb Bio Inc

CTMX

CytomX Therapeutics Inc

Market Cap

CLYM$630M

CTMX$559M

Enterprise Value

CLYM$586M

CTMX$542M

Price

CLYM$11.00

CTMX$2.57

P/E Ratio

CLYMN/A

CTMXN/A

P/S Ratio

CLYM0.00x

CTMX30.57x

EV/Sales

CLYM0.00x

CTMX29.63x

EV/EBITDA

CLYM0.00x

CTMX22.17x

P/B Ratio

CLYM2.62x

CTMX1.85x

P/FCF Ratio

CLYMN/A

CTMXN/A

EV/FCF

CLYM-11.04x

CTMX-6.55x

PEG Ratio

CLYMN/A

CTMXN/A

Forward P/E (NTM)

CLYMN/A

CTMXN/A

Forward P/S (NTM)

CLYMN/A

CTMX32.52x

Revenue (TTM)

CLYM$0

CTMX$18M

Revenue Growth (YoY)

CLYMN/A

CTMX-87.0%

Forward Rev Growth

CLYM27.3%

CTMX35.7%

Gross Margin (TTM)

CLYM0.0%

CTMX0.0%

Operating Margin (TTM)

CLYM0.0%

CTMX0.0%

EBITDA Margin (TTM)

CLYM0.0%

CTMX-471.6%

Net Margin (TTM)

CLYM0.0%

CTMX-451.6%

FCF Margin (TTM)

CLYMN/A

CTMX-452.1%

Net Income (TTM)

CLYM$-58M

CTMX$-83M

FCF (TTM)

CLYM$-53M

CTMX$-83M

EPS (TTM)

CLYM-$0.76

CTMX-$0.38

ROE (TTM)

CLYM-3179.0%

CTMX-3846.0%

ROA (TTM)

CLYM-3079.0%

CTMX-3033.0%

ROIC (TTM)

CLYM-3179.0%

CTMX-3846.0%

Cash

CLYM$44M

CTMX$17M

Debt

CLYM$0

CTMX$0

Net Cash/Debt

CLYM$44M

CTMX$17M

Current Ratio (TTM)

CLYM31.45x

CTMX9.36x

Quick Ratio (TTM)

CLYM30.86x

CTMX9.25x

Debt/Equity (TTM)

CLYM0.00x

CTMX0.00x

Debt/Assets (TTM)

CLYM0.0%

CTMX0.0%

Interest Coverage (TTM)

CLYMN/A

CTMXN/A

Net Debt/EBITDA (TTM)

CLYM0.00x

CTMX0.00x

Beta

CLYM-0.01

CTMX2.26

52W Performance

CLYM511.1%

CTMX-23.7%

YTD Performance

CLYM193.3%

CTMX-39.5%

% from 52W High

CLYM-40.0%

CTMX-68.7%

% from 52W Low

CLYM572.8%

CTMX5.8%

Asset Turnover (TTM)

CLYM0.00x

CTMX0.07x

FCF Yield (TTM)

CLYM-8.4%

CTMX-14.8%

Earnings Yield (TTM)

CLYM-9.1%

CTMX-14.8%

Dividend Yield (TTM)

CLYMN/A

CTMXN/A

Rule of 40

CLYM0.0

CTMX-539.1

EV/GP/RG

CLYMN/A

CTMXN/A

Ticker research

View CLYM research View CTMX research

Metric	CLYM Climb Bio Inc	CTMX CytomX Therapeutics Inc
Market & Valuation
Market Cap	$630M	$559M
Enterprise Value	$586M	$542M
Price	$11.00	$2.57
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	30.57x
EV/Sales	0.00x	29.63x
EV/EBITDA	0.00x	22.17x
P/B Ratio	2.62x	1.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.04x	-6.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	32.52x
Revenue & Growth
Revenue (TTM)	$0	$18M
Revenue Growth (YoY)	N/A	-87.0%
Forward Rev Growth	27.3%	35.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-471.6%
Net Margin (TTM)	0.0%	-451.6%
FCF Margin (TTM)	N/A	-452.1%
Net Income (TTM)	$-58M	$-83M
FCF (TTM)	$-53M	$-83M
EPS (TTM)	-$0.76	-$0.38
ROE (TTM)	-3179.0%	-3846.0%
ROA (TTM)	-3079.0%	-3033.0%
ROIC (TTM)	-3179.0%	-3846.0%
Financial Health
Cash	$44M	$17M
Debt	$0	$0
Net Cash/Debt	$44M	$17M
Current Ratio (TTM)	31.45x	9.36x
Quick Ratio (TTM)	30.86x	9.25x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.01	2.26
52W Performance	511.1%	-23.7%
YTD Performance	193.3%	-39.5%
% from 52W High	-40.0%	-68.7%
% from 52W Low	572.8%	5.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.07x
FCF Yield (TTM)	-8.4%	-14.8%
Earnings Yield (TTM)	-9.1%	-14.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-539.1
EV/GP/RG	N/A	N/A
Ticker research	View CLYM research	View CTMX research